Doctors say drugs that improve muscle mass could benefit older or infirm people at greater risk of falls and fractures ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...
A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.
Senators questioned Novo Nordisk CEO Lars Jørgensen ... that shows significant potential for weight loss that comes in pill form. A new study finds the drug semaglutide appears to lower ...
Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ...